Office of Inspector General Investigating FDA’s Accelerated Approvals

We believe an independent assessment is the best manner in which to determine whether any interactions that occurred between the manufacturer and the agency’s review staff were inconsistent with FDA’s policies and procedures.

— Dr. Janet Woodcock (@DrWoodcockFDA) July 9, 2021